Patsy Newitt

Melville, N.Y.-based North American Partners in Anesthesia is expanding anesthesia services to more Virginia patients through its partnership with Bon Secours-Richmond (Va.), a subsidiary of Bon Secours Mercy Health.

Raleigh (N.C.) Orthopaedic Surgery Center's outpatient total joint program grew by 40 percent in 2020, with the center completing 348 total joint procedures. The center is expected to exceed last year's total in 2021. 

ASCs can partner with private equity-backed platforms as a way to capitalize on future value and mitigate risks, but some ASC leaders warn that partnering with private equity firms requires consideration of costs outside the financial.

Natick, Mass.-based New England Surgical Suites announced the completion of the center's first total shoulder replacement.

Cardinal Health's efforts to increase supply chain visibility is a critical step to combat the personal protective equipment shortages many ASCs are still experiencing a year into the pandemic. 

Salix Pharmaceuticals, a gastrointestinal-focused specialty pharmaceutical company, announced the launch of its website, GastroHub for Advanced Practice Providers, that provides resources and educational materials for GI nurse practitioners and physician assistants. 

A partnership between Raleigh, N.C.-based ASC developer Compass Surgical Partners, Tampa-based Orthopaedic Associates of West Florida and Orthopaedic Specialties of Tampa Bay announced a new joint, spine and orthopedic ASC in West Florida.

Leading healthcare solutions provider Henry Schein announced a new investment in Atlanta-based Stradis Medical, which will strengthen Henry Schein's focus on the ASC market. 

The COVID-19 pandemic required ASC administrators to work adaptably and creatively during the past year. Here are 10 ASC administrators to know:

The ASC industry has seen an influx of private equity interest, consolidating the industry. Ophthalmologist Richard Lee, MD, who works at Oakland, Calif.-based Eye MD Laser & Surgery Center, spoke with Becker's ASC Review on why his ASC hasn't sold…